Thomas J Spencer

Massachusetts General Hospital

$6,919,088

Attributed

$6,919,088

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2005–19

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

Funding mix

By agency

FDA$3,874,719 · 1

NIH$3,044,369 · 3

By mechanism

U01$3,874,719 · 1

R01$2,664,890 · 1

R29$344,521 · 1

P51$34,958 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Georges El Fakhri$43,967,178
Braden Kuo$7,375,946
Joel S Finkelstein$18,947,740
Xandra Owens Breakefield$30,735,276
Carol A. Mathews$10,182,403

Others in their field

Top investigators on “Comorbidity”

Judith S. Currier · University Of California Los Angeles$289,742,226
Daniel R Kuritzkes · Brigham And Women'S Hospital$224,688,794
Joseph J. Eron · Univ Of North Carolina Chapel Hill$219,177,300
Sharon A Nachman · Johns Hopkins University$212,395,175
Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$130,117,932
Barbara Driver · Westat, Inc.$112,337,014

Research focus

ComorbidityAttention Deficit DisorderFunctional AbilityInterviewHuman SubjectNeuropsychologyClinical ResearchNeurobiologyIodineMolecular GeneticsHuman Therapy EvaluationDrug ToleranceBioimaging /Biomedical ImagingDrug Screening /EvaluationMental Disorder ChemotherapyCognitionDopamine TransporterClinical Trial Phase IAdult Human (21+)Drug Adverse EffectDrug Administration Rate /DurationDrug WithdrawalMethylphenidatePerformance